Tel: +0898-36379999
Fax: +0898-36379999
Add: No.9, Changbin West 4th Street, Xiuying district, Haikou city, Hainan province
The pain department at the Hainan Cancer Hospital provides first-level diagnosis and treatment that is subject to approval by the former provincial health and family planning commission. Relying on the background of tumor specialty in our hospital and adhering to the overall treatment concept, the department can carry out a number of characteristic diagnosis and treatment techniques on cancer pain. At the same time, it also has special diagnosis and treatment methods for other chronic pain diseases such as herpes zoster and its subsequent neuralgia.
The pain department now has 2 doctors, including 1 chief physician and 1 resident physician.
Diagnosis and treatment:
Characteristic treatment:
1. Refractory cancer pain associated with advanced tumors, including refractory pain caused by bone metastasis in advanced tumors such as pancreatic cancer, liver cancer, lung cancer, and endometrial cancer.
2. Minimally invasive interventional therapy for acute herpes zoster and its subsequent neuralgia.
3. Palliative rehabilitation for patients with advanced tumors.
Routine treatment:
1、Head and facial pain, such as trigeminal neuralgia, occipital great neuralgia, etc.
2All kinds of chronic neck, waist and leg pain: such as cervical spondylosis, periarthritis of shoulder, waist and leg pain, etc.
3、Various unexplained pains.
Characteristic therapeutic technique
I.PCA automatic analgesia technology. The principle of PCA technology is to use microcomputers to set various technical parameters on the analgesic pump according to the patient's condition so that the analgesic drugs can be administered to the patient in a safe and effective range.
II.Nerve block technique. It is a characteristic treatment method of the pain department to use nerve block technology to inject various therapeutic drugs directly into the nerve stem or spinal canal to relieve pain, improve blood circulation and treat diseases.
III.Nerve damage technology. Under the guidance of CT or DSA, an appropriate amount of nerve destruction drug is injected around the damaged nerve to cause demyelinating changes of the nerve and damage the conduction function of the nerve fiber to achieve a long-term analgesic effect. Including 1. Peritoneal plexus destruction, which is suitable for pain caused by upper abdominal tumors such as pancreatic cancer, gastric cancer, liver cancer, and esophageal cancer, as well as pain from retroperitoneal metastasis of other malignancies. 2. The technique of upper and lower abdominal nerve destruction, applicable to patients with pelvic primary tumors or metastatic tumors caused by abdominal and pelvic visceral pain. 3. Odd ganglion destruction, suitable for local pain in the anal perineal area caused by rectal cancer or other malignant tumors.
IV. Intrathecal infusion technology. This method can directly effect the drug on the spinal cord and brain. The dose of the drug is only 1/300 of the dose required by oral administration, which is suitable for almost all patients with advanced cancer pain.